Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06390371 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Primary completion date changed from estimate of Jun 2026 to May 18, 2026
    • Start date: May 27, 2024 to May 18, 2024
    • Site details revised
    v9
  2. Primary completion date: Dec 2025 to Jun 2026
    • Study completion date: Dec 2025 to Dec 2026
    v8
  3. Site contact updatedv7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary completion date: Apr 2025 to Dec 2025v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Oct 2024 to Apr 2025
    • Study completion date: Dec 2024 to Dec 2025
    • Eligibility criteria expanded, about 5 words
    v4
  2. Start date changed from estimate of Jun 6, 2024 to May 27, 2024v3
  3. Start date: May 6, 2024 to Jun 6, 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents \& young adults (16-25 years old) with Type 1 Diabetes (T1D). The main questions it aims to answer are: * Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it? * Do patients and healthcare providers like using the spotlight AQ survey? Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey.
Trial Details
NCT Number NCT06390371
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions
(from sponsor)		 Type 1 Diabetes Mellitus
Related terms Diabetes Mellitus, Type 1
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov